kabutan

Soiken Holdings Inc.(2385) Summary

2385
TSE Growth
Soiken Holdings Inc.
258
JPY
+2
(+0.78%)
Dec 5, 11:28 am JST
1.66
USD
Dec 4, 9:28 pm EST
Result
PTS
outside of trading hours
257.9
Dec 5, 11:14 am JST
Summary Chart Historical News Financial Result
PER
224.3
PBR
1.13
Yield
3.88%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
256 JPY 1.65 USD
Previous Close Dec 4
256 JPY 1.64 USD
High Dec 5, 9:10 am
269 JPY 1.73 USD
Low Dec 5, 10:29 am
252 JPY 1.62 USD
Volume
273,200
Trading Value
0.07B JPY 0.46M USD
VWAP
259.93 JPY 1.68 USD
Minimum Trading Value
25,800 JPY 166 USD
Market Cap
6.75B JPY 0.04B USD
Number of Trades
342
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Mid
1-Year Average
304
1-Year High Dec 1, 2025
9,730
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 0 796,500
Nov 21, 2025 0 827,800
Nov 14, 2025 1,700 1,055,200 620.71
Nov 7, 2025 0 928,000
Oct 31, 2025 0 918,700
Company Profile
Soiken Holdings Inc. is a venture business originating from Osaka University. The company's main focus is on cosmetics, but it also engages in functional food evaluation testing and anti-fatigue food products.
Sector
Services
Soiken Holdings Inc. was established as a biotech venture from Osaka University and operates in five business areas: bio-evaluation systems, healthcare support, cosmetics, health supplements, and functional ingredient development. In the bio-evaluation systems business, the company conducts evaluation tests using biomarkers and supports clinical research for pharmaceuticals. The healthcare support business offers services such as health checkups, specific health guidance, and diabetes severity prevention programs. The cosmetics business develops and markets its own brand using placenta extract. In the health supplements business, "Imida Peptide" is sold as the main product. The functional ingredient development business focuses on developing and selling functional materials such as lactoferrin.